Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Generation Bio Co
GBIOCurrent price
2.33 USD
+0.07 USD (+3.10%)
Last closed
2.24 USD
Company
generationbio.com
ISIN
US37148K1007
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
150 835 104 USD
Yield for 12 month
+153.04 %
1Y
3Y
5Y
10Y
15Y
GBIO
Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. The company develops cell-targeted lipid nanoparticle (ctLNP) platform, a modular delivery system for nucleic acids to avoid off-target clearance by the liver and spleen that enables ctLNPs to persist in systemic circulation, which allows for highly selective and potent ligand-driven targeting to specific tissues and cell types; and novel immune-quiet DNA (iqDNA) to enable long-lasting high levels of gene expression from non-integrating episomes and avoids innate immune sensors that have long prevented DNA from use in non-viral systems. It uses its platform for developing a portfolio of programs for treating cancer, autoimmune, hematologic disorders, prioritizing sickle cell, beta-thalassemia, and hemophilia A diseases, as well as for other tissues and cell types, including retina, skeletal muscle, and central nervous system. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Address: 301 Binney Street, Cambridge, MA, United States, 02142
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
7.5 USDP/E ratio
–Dividend Yield
–Current Year
+5 904 000 USD
Last Year
+880 000 USD
Current Quarter
+4 091 000 USD
Last Quarter
+4 059 000 USD
Current Year
+641 000 USD
Last Year
-5 130 000 USD
Current Quarter
+2 828 000 USD
Last Quarter
+2 747 000 USD
Key Figures GBIO
1 year
3 years
5 years
10 years
EBITDA
-106 701 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-20.87 %
PEG Ratio
–
Return On Equity TTM
-85.71 %
Wall Street Target Price
7.5 USD
Revenue TTM
13 174 000 USD
Book Value
1.73 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
364.9 %
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.39 USD
Diluted Eps TTM
-2.39 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics GBIO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History GBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation GBIO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
2.114
Price Sales TTM
11.4495
Enterprise Value EBITDA
-0.3385
Price Book MRQ
1.307
Financials GBIO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators GBIO
For 52 weeks
0.86 USD
4.65 USD
50 Day MA
2.49 USD
Shares Short Prior Month
2 143 783
200 Day MA
2.74 USD
Short Ratio
16.4
Shares Short
2 005 269
Short Percent
5.02 %
BeatStart